CPH
Physician Daily · Monday, August 24, 2026
Newsletters Sign in ON AIR
CrosspointHealthNEWS + REFERENCE LIBRARY
Diagnosis Sheet Disruptive, Impulse-Control, and Conduct Disorders DSM-5-TR 312.34 | ICD-10-CM F63.81

Intermittent Explosive Disorder

Recurrent impulsive aggressive outbursts grossly out of proportion to provocation, unplanned, and followed by remorse and distress.

Prevalence~2.7% 12-mo; ~7.3% lifetime
Typical onsetLate childhood to teens
Sex ratioMore common in males
CourseChronic; years of episodes

Clinical picture

  • Outbursts begin abruptly, peak within minutes, and end within about 30 minutes, followed by remorse, embarrassment, and physical exhaustion.
  • Aggression is grossly out of proportion to the trigger, which is often trivial: a spilled drink, a traffic maneuver, or a perceived slight.
  • Presentation includes verbal tirades, property destruction such as punched walls and thrown objects, and assaults on people or animals.
  • Between episodes the patient generally functions well, which is why partners describe two different people living in the same house.
  • Legal, occupational, and relational consequences accumulate: arrests, job loss, divorce, and recurrent injuries to hands and knuckles.
  • Patients rarely self-refer and usually arrive after a court mandate, a partner ultimatum, or an emergency visit for a fight-related injury.

Criteria snapshot

  • Recurrent behavioral outbursts reflecting a failure to control aggressive impulses, satisfying either a high-frequency or a high-severity pattern.
  • The high-frequency pattern requires verbal or nonassaultive physical aggression about twice weekly for 3 months without damage or injury.
  • The high-severity pattern requires three outbursts causing damage, destruction, or physical injury to people or animals within 12 months.
  • Aggression must be grossly disproportionate to provocation, impulsive rather than premeditated, and not committed for tangible gain or coercion.
  • Chronological or developmental age must be at least 6 years, and other disorders, substances, and medical causes must be excluded first.

Neurobiology

  • Serotonergic hypofunction is the best-replicated finding, with blunted prolactin response to fenfluramine and low CSF 5-HIAA in impulsive aggression.
  • Amygdala hyperreactivity to angry faces with reduced orbitofrontal and anterior cingulate modulation defines the top-down control failure.
  • Elevated peripheral inflammatory markers, including C-reactive protein and interleukin-6, correlate with lifetime aggression scores.
  • Heritability estimates for impulsive aggression run near 40 to 50%, with tryptophan hydroxylase and MAOA variants repeatedly implicated.
  • Childhood trauma, traumatic brain injury, and an elevated testosterone-to-cortisol ratio all raise reactive aggression risk.
  • Medical burden is elevated in epidemiologic samples, including hypertension, coronary artery disease, stroke, and diabetes.

Psychology

  • Hostile attribution bias leads patients to read ambiguous social cues as deliberately provocative, priming an immediate aggressive response.
  • Deficits in emotion regulation and distress tolerance mean anger escalates from baseline to maximum with no usable intermediate steps.
  • Aggression is negatively reinforced when it ends the aversive arousal and positively reinforced whenever other people back down.
  • Social learning in violent households models aggression as the normative and effective response to frustration and interpersonal conflict.
  • Rumination between episodes and weak problem-solving skills sustain a chronically elevated baseline of irritability and readiness to react.

Differential & comorbidity

  • Separate the instrumental, premeditated aggression of antisocial personality disorder and conduct disorder from these impulsive outbursts.
  • Borderline personality disorder aggression is embedded in abandonment fear and pervasive affective instability across the clinical picture.
  • Rule out mania, psychosis, substance intoxication or withdrawal, delirium, traumatic brain injury, and complex partial seizures.
  • It is not diagnosed when disruptive mood dysregulation disorder criteria are met, and it should not be diagnosed before age 6.
  • Comorbidity with depressive, anxiety, and substance use disorders is very high, and suicidal behavior risk is significantly elevated.

Pharmacologic treatment

  • Fluoxetine 20-60 mg/day reduced impulsive aggression versus placebo in a randomized trial, though full remission occurred in a minority.
  • Other SSRIs are used similarly, and 8 to 12 weeks at an adequate dose is needed before judging response on aggression outcomes.
  • Divalproex improved impulsive aggression within cluster B personality disorder, but the overall trial was negative; monitor LFTs and platelets.
  • Anticonvulsant mood stabilizers such as oxcarbazepine or carbamazepine, and lithium, have supportive but limited evidence.
  • Avoid benzodiazepines, which disinhibit and can worsen aggression, and reserve antipsychotics for comorbid psychosis or mania.

Psychotherapy

  • Cognitive-behavioral therapy for anger over 12 weeks, in group or individual format, reduced aggression versus wait list in a randomized trial.
  • Core components are relaxation training, cognitive restructuring of hostile attributions, and explicit relapse prevention planning.
  • Dialectical behavior therapy skills, particularly distress tolerance and emotion regulation, transfer well to impulsive aggression.
  • Couples and family therapy addresses the interaction sequences that precede outbursts and repairs the relational damage that follows them.
  • Anger monitoring logs recording trigger, intensity, duration, and consequence form the backbone of every effective treatment protocol.

Adjunct options

  • Safety planning comes first: assess weapon access, arrange firearm removal, and document intimate partner violence risk at every visit.
  • Treat comorbid alcohol and stimulant use disorders concurrently, since intoxication is the most common proximal trigger for outbursts.
  • Measure with the Overt Aggression Scale-Modified or the Buss-Perry Aggression Questionnaire to track frequency and severity over time.
  • Court-mandated batterer intervention programs are not a substitute for treating impulsive aggression and show only modest effects.
  • Address sleep loss, chronic pain, and anabolic steroid or stimulant use, all of which measurably lower the aggression threshold.

Clinical pearls

  • Impulsive and regretted, not planned and profitable: that is IED, not antisocial.
  • Ask about firearm access and partner violence before anything else.
  • Benzodiazepines disinhibit; they are the wrong drug for explosive anger.

References

  • American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787
  • Coccaro, E. F. (2012). Intermittent explosive disorder as a disorder of impulsive aggression for DSM-5. The American Journal of Psychiatry, 169(6), 577-588. https://doi.org/10.1176/appi.ajp.2012.11081259
  • Coccaro, E. F., Lee, R. J., & Kavoussi, R. J. (2009). A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder. The Journal of Clinical Psychiatry, 70(5), 653-662. https://doi.org/10.4088/JCP.08m04150
  • Fariba, K. A., & Gokarakonda, S. B. (2023). Impulse control disorders. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK562279/
  • Hollander, E., Tracy, K. A., Swann, A. C., Coccaro, E. F., McElroy, S. L., Wozniak, P., Sommerville, K. W., & Nemeroff, C. B. (2003). Divalproex in the treatment of impulsive aggression: Efficacy in cluster B personality disorders. Neuropsychopharmacology, 28(6), 1186-1197. https://doi.org/10.1038/sj.npp.1300153
  • Kessler, R. C., Coccaro, E. F., Fava, M., Jaeger, S., Jin, R., & Walters, E. (2006). The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication. Archives of General Psychiatry, 63(6), 669-678. https://doi.org/10.1001/archpsyc.63.6.669
  • McCloskey, M. S., Noblett, K. L., Deffenbacher, J. L., Gollan, J. K., & Coccaro, E. F. (2008). Cognitive-behavioral therapy for intermittent explosive disorder: A pilot randomized clinical trial. Journal of Consulting and Clinical Psychology, 76(5), 876-886. https://doi.org/10.1037/0022-006X.76.5.876
  • Sadock, B. J., Sadock, V. A., & Ruiz, P. (2021). Kaplan & Sadock's synopsis of psychiatry (12th ed.). Wolters Kluwer.